![Collaboration with GlaxoSmithKline to target NMT in malaria](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1528098694369_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
New collaboration
Collaboration with GlaxoSmithKline to target NMT in malaria
Imperial and GSK have signed a collaborative agreement to work on the development of antimalarial agents targeting N-myristoyltransferase (NMT).